技术在使用立体定向体部放射治疗的临床试验中的作用。
The role of technology in clinical trials using stereotactic body radiotherapy.
作者信息
Aznar Marianne, Méndez Romero Alejandra, Heijmen Ben J M
机构信息
1 Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
2 Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
出版信息
Br J Radiol. 2017 Mar;90(1071):20160930. doi: 10.1259/bjr.20160930. Epub 2017 Feb 17.
Abstract
Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today's technology is used correctly and close to its optimal potential for accuracy. The credentialing procedure of SABR needs to be extensive, but this investment will benefit the trial itself, the patients and the professionals involved.
摘要
立体定向体部放射治疗是一种高度技术驱动的治疗方式。机房内成像和先进放疗输送技术的更广泛应用使得更多机构能够提供立体定向消融放疗（SABR）。尽管仍存在一些技术挑战，但下一代SABR临床试验的关键在于正确使用当今的技术，并使其接近其在准确性方面的最佳潜力。SABR的认证程序需要全面，但这种投入将使试验本身、患者以及相关专业人员受益。
相似文献
1
The role of technology in clinical trials using stereotactic body radiotherapy.技术在使用立体定向体部放射治疗的临床试验中的作用。
Br J Radiol. 2017 Mar;90(1071):20160930. doi: 10.1259/bjr.20160930. Epub 2017 Feb 17.
2
Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.LARK（TROG 17.03）临床试验研究方案：一项使用千伏级术中实时监测评估肝消融放射治疗剂量学影响的 II 期临床试验。
BMC Cancer. 2021 May 3;21(1):494. doi: 10.1186/s12885-021-08184-x.
3
Stereotactic ablative body radiotherapy for lung cancer.立体定向消融体部放射治疗肺癌
Clin Oncol (R Coll Radiol). 2015 May;27(5):280-9. doi: 10.1016/j.clon.2015.01.006. Epub 2015 Mar 4.
4
Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction.前列腺癌立体定向消融放疗的临床试验：进展与未来方向
Future Oncol. 2015;11(5):819-31. doi: 10.2217/fon.15.14.
5
Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial.多中心试验中的椎体立体定向消融放疗的认证。
Phys Med. 2020 Apr;72:16-21. doi: 10.1016/j.ejmp.2020.03.004. Epub 2020 Mar 17.
6
Stereotactic ablative radiotherapy in the UK: current status and developments.立体定向消融放疗在英国：现状与进展。
Br J Radiol. 2013 Sep;86(1029):20130331. doi: 10.1259/bjr.20130331. Epub 2013 Jul 19.
7
Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.对澳大利亚和新西兰的放疗中心进行资质认定，以开展TROG 09.02（Chisel）试验，这是一项关于早期肺癌立体定向消融体部放疗的III期临床试验。
Br J Radiol. 2018 May;91(1085):20170737. doi: 10.1259/bjr.20170737. Epub 2018 Mar 6.
8
Targeting Oligometastasis with Stereotactic Ablative Radiation Therapy or Surgery in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review of Prospective Clinical Trials.立体定向消融放疗或手术治疗转移性激素敏感前列腺癌寡转移灶：前瞻性临床试验的系统评价。
Eur Urol Oncol. 2020 Oct;3(5):582-593. doi: 10.1016/j.euo.2020.07.004. Epub 2020 Sep 3.
9
Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer.立体定向消融体部放射治疗中高危前列腺癌。
Cancer J. 2020 Jan/Feb;26(1):38-42. doi: 10.1097/PPO.0000000000000425.
10
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney.立体定向消融放疗治疗原发性肾细胞癌（包括孤立肾患者）后的长期肾功能结局：来自国际肾脏放射外科肿瘤学联盟的报告
Eur Urol Oncol. 2024 Dec;7(6):1527-1534. doi: 10.1016/j.euo.2024.06.012. Epub 2024 Jul 9.
引用本文的文献
1
Recent advances in radiation oncology.放射肿瘤学的最新进展。
Ecancermedicalscience. 2017 Nov 30;11:785. doi: 10.3332/ecancer.2017.785. eCollection 2017.
本文引用的文献
1
A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.立体定向消融放疗治疗早期原发性肺癌后结局的系统评价。
Br J Radiol. 2017 Mar;90(1071):20160732. doi: 10.1259/bjr.20160732. Epub 2017 Feb 17.
2
Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.Lungtech，一项关于立体定向体部放疗（SBRT）用于中央型肺肿瘤的欧洲癌症研究与治疗组织（EORTC）II期试验——临床物理学视角
Radiat Oncol. 2016 Jan 20;11:7. doi: 10.1186/s13014-015-0567-5.
3
Multileaf Collimator Tracking Improves Dose Delivery for Prostate Cancer Radiation Therapy: Results of the First Clinical Trial.多叶准直器跟踪技术可提高前列腺癌放射治疗的剂量传递：首次临床试验结果。
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1141-1147. doi: 10.1016/j.ijrobp.2015.04.024. Epub 2015 Apr 17.
4
Sub-millimeter spine position monitoring for stereotactic body radiotherapy using offline digital tomosynthesis.使用离线数字断层合成技术进行立体定向体部放射治疗的亚毫米级脊柱位置监测。
Radiother Oncol. 2015 May;115(2):223-8. doi: 10.1016/j.radonc.2015.04.004. Epub 2015 Apr 21.
5
Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary.立体定向放射外科和立体定向体部放射治疗中的质量与安全考量：执行摘要。
Pract Radiat Oncol. 2012 Jan-Mar;2(1):2-9. doi: 10.1016/j.prro.2011.06.014. Epub 2011 Sep 15.
6
Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis.带电粒子治疗与光子治疗肝癌患者的比较：系统评价和荟萃分析。
Radiother Oncol. 2015 Mar;114(3):289-95. doi: 10.1016/j.radonc.2014.11.033. Epub 2014 Dec 9.
7
Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review.使用Vero万向直线加速器系统对患者进行实时肿瘤追踪治疗：实施与首次评估
Radiother Oncol. 2014 Sep;112(3):343-51. doi: 10.1016/j.radonc.2014.05.017. Epub 2014 Jul 18.
8
Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.通过在线图像引导进行肺部立体定向体部放疗（SBRT）时剂量与临床结果的剂量反应关系。
Radiother Oncol. 2014 Mar;110(3):499-504. doi: 10.1016/j.radonc.2014.02.002. Epub 2014 Mar 11.
9
Motion compensated digital tomosynthesis.运动补偿数字断层合成术。
Radiother Oncol. 2013 Dec;109(3):398-403. doi: 10.1016/j.radonc.2013.09.002. Epub 2013 Oct 3.
10
Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.自适应肝脏立体定向体部放射治疗：自动每日计划再优化可防止因解剖变形导致的剂量输送下降。
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1016-21. doi: 10.1016/j.ijrobp.2013.08.009. Epub 2013 Sep 24.
Zotero 插件